Skip to main content

Table 2 Higher risk of systemic lupus erythematosus in anti-Toxoplasma gondii antibodies immunoglobulin G population

From: Anti-Toxoplasma gondii antibodies as a risk factor for the prevalence and severity of systemic lupus erythematosus

ATxA-IgG type

Healthy controls (N, %)

SLE patients (N, %)

Odds ratio (95% CI)

Odds ratio (95% CI) (age/sex adjusted)

P-valuea

ATxA-IgG−

855 (94.2)

719 (83.3)

Reference

Reference

 

ATxA IgG+

53 (5.8)

144 (16.7)

3.23 (2.32–4.49)

2.48 (1.70–3.62)

 < 0.0001*

  1. ATxA IgG+, Anti-Toxoplasma gondii antibodies immunoglobulin G-positive, ATxA IgG− anti-Toxoplasma gondii antibodies immunoglobulin G-negative, CI confidence interval
  2. *Statistically significant
  3. aP value for the comparison with matched healthy controls